As used in the Wholesale Prescription Drug Importation Act:

1. A. "Canadian supplier" means a manufacturer, wholesale distributor or pharmacy that is appropriately licensed or permitted under Canadian federal or provincial laws and rules to manufacture, distribute or dispense prescription drugs;
2. B. "committee" means the prescription drug importation advisory committee;
3. C. "department" or "authority" means the health care authority department;

4. D. "eligible prescription drug" means a drug eligible for importation that:

   1. (1) meets the United States food and drug administration's standards related to safety, effectiveness, misbranding and adulteration;
   2. (2) does not violate federal patent laws;
   3. (3) is expected to generate cost savings; and
   4. (4) is not a controlled substance;
5. E. "program" means the wholesale prescription drug importation program; and
6. F. "state drug wholesaler" means a licensed wholesale drug distributor that contracts with the state to import eligible prescription drugs from a Canadian supplier.

History: Laws 2020, ch. 45, § 2; 2024, ch. 39, § 58.

ANNOTATIONS

The 2024 amendment, effective July 1, 2024, in Subsection C, after "'department'" added "or authority", after "means the" deleted "department of", and after "health" added "care authority department".